DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Gulley JL, Rajan A, Spigel DR. et al.
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): Dose-expansion cohort of a multicentre, open-label, phase 1b trial.
Lancet Oncol 2017;
18: 599-610
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.